Jiangsu Hengrui Medicine
600276.SS
#483
Rank
HK$405.81 B
Marketcap
HK$61.14
Share price
8.75%
Change (1 day)
7.58%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Quarterly Reports

Thumbnail Jiangsu Hengrui Medicine
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: Chinese

View Quarterly Report